Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-11-25
2000-01-04
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, 530399, A61K 3818
Patent
active
060110090
ABSTRACT:
The present invention provides a novel method of determining the presence of angiogenesis in a subject comprising detecting the presence of scatter factor in the subject.
REFERENCES:
Zhan et al., J. Cell. Biochem., 56/Suppl. 19, p. 208-216, 1994.
Kuwano et al., Gann. Monogr. Cancer Res., vol. 42 pp. 113-125, 1994.
Rosen et al., EXS, vol. 65, pp. 301-310, 1993.
Rosen et al., Ciba Found. Symp., vol. 212, pp. 215-229, 1997.
Vande Woude et al., Ciba Found. Symp., vol. 212, pp. 119-132, 1997.
Goldberg Itzhak D.
Rosen Eliot M.
North Shore University Hospital Research Corporation
Sayala Chhaya D.
LandOfFree
Method for determining angiogenesis using scatter factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining angiogenesis using scatter factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining angiogenesis using scatter factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072678